Pivotal bioVenture Partners CNS Fund I, L.P. — Form D
Pivotal bioVenture Partners CNS Fund I, L.P. of WILMINGTON, DE, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2021-04-23. Industry: Pooled Investment Fund.
Offering
- Filed: 2021-04-23
- Form: D
- Accession: 0001857521-21-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-396888
Issuer
- Name: Pivotal bioVenture Partners CNS Fund I, L.P.
- CIK: 0001857521
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: THE CORPORATION TRUST COMPANY, WILMINGTON, DE, 19801
- Phone: (302) 658-7581
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Peter Bisgaard | Director | South San Francisco, CA |
| Vincent Sai Sing Cheung | Director | Hong Kong, K3 |
| Richard Coles | Director | Grand Cayman, E9 |
More